Technology

Athersys

$2.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 4:24 PM UTC today

Why Robinhood?

You can buy or sell Athersys and other stocks, options, and ETFs commission-free!

About ATHX

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH. The listed name for ATHX is Athersys, Inc. Common Stock.

CEO
Gil van Bokkelen
Employees
83
Headquarters
Cleveland, Ohio
Founded
1995
Market Cap
419.57M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.99M
High Today
$2.28
Low Today
$2.12
Open Price
$2.28
Volume
1.58M
52 Week High
$4.38
52 Week Low
$1.13

Collections

ATHX Earnings

-$0.11
-$0.07
-$0.04
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 16, After Hours

You May Also Like

IBHB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure